Global Lateral Epicondylitis Treatment Market Forecasts: 2019-2023 - Leading Players Are Bayer, GlaxoSmithKline, Johnson & Johnson Services, Merck Sharp & Dohme, and Pfizer - ResearchAndMarkets.com

The "Global Lateral Epicondylitis Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Analysts have predicted that the lateral epicondylitis treatment market will register a CAGR of over 3% by 2023.

Various government and non-government organizations are initiating certain programs to increase awareness among people and avoid delays in diagnosis. Hence, an increase in the number of organizations and institutes that raise awareness among people about lateral epicondylitis is expected to drive the growth of the global lateral epicondylitis treatment market during the forecast period.

Growing prevalence of risk factors for lateral epicondylitis

The growing prevalence of these medical conditions is the major risk factor for the development of lateral epicondylitis. The increase in the number of patients with these diseases may develop lateral epicondylitis. This, in turn, is expected to aid in the use of available treatments and anticipated treatments and drive the growth of the global lateral epicondylitis treatment market during the forecast period.

Lack of approved treatment

Lateral epicondylitis is a common problem with many available treatment options, but largely recommended treatment option is the combination of corticosteroids, physiotherapy, and bracing. However, there is no approved treatment for lateral epicondylitis. Therefore, the lack of approved treatments in the market for lateral epicondylitis is expected to hamper the growth of the global lateral epicondylitis treatment market during the forecast period.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Players

• Bayer AG
• GlaxoSmithKline PLC
• Johnson & Johnson Services Inc.
• Merck Sharp & Dohme Corp.
• Pfizer Inc.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY TYPE

• Comparison by type
• Non-surgical treatment - Market size and forecast 2018-2023
• Surgical treatment - Market size and forecast 2018-2023
• Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 12: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bayer AG
• GlaxoSmithKline PLC
• Johnson & Johnson Services Inc.
• Merck Sharp & Dohme Corp.
• Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/research/8266kg/global_lateral?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190220005768/en/